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Gendered innovation in health and medicine
Zusammenfassung
Gendered Innovation in Gesundheit und Me-
dizin
„Gendered Innovations“ integriert eine Sex- 
und Genderanalyse in alle Phasen der biome-
dizinischen und Gesundheitsforschung, um 
Ex zellenz und Qualität auf Ergebnisseite zu si-
chern. Der Beitrag stellt die interdisziplinären 
internationalen Kooperationsbemühungen 
dar, in deren Rahmen sowohl zeitgemäße Me-
thoden der geschlechterfokussier ten Analyse 
im Bereich von Gesundheit und Medizin ent-
wickelt als auch Fallstudien durchgeführt wur-
den: zur Osteoporoseforschung bei Männern, 
zu genetischen Faktoren der Geschlechtsbe-
stimmung, Herzerkrankungen bei Frauen, 
Stammzellenforschung, Tierversuchen, Nutri-
genomik und zum „Degendering“ bei Knie-
implantaten. Der Beitrag schließt mit einem 
kurzen Blick auf kanadische, US-amerikani-
sche und europäische Gesundheitsinstitute, 
medizinische Curricula und den Umgang 
peer-reviewter Zeitschriften mit Forschungs-
berichten über Sex-/Genderanalysen.
Schlüsselwörter 
Gendered Innovations, Sex-/Genderanalyse, 
Biomedizin, Gesundheitsforschung
Summary
“Gendered Innovations” integrates sex and 
gender analysis into all phases of biomedical 
and health research to assure excellence and 
quality in outcomes. This article reports on the 
interdisciplinary, international collaboration 
that produced: 1) state-of-the-art methods of 
sex and gender analysis for health and medi-
cine; and 2) case studies to illustrate how gen-
der analysis leads to discovery in biomedicine 
and better outcomes in health research: os-
teoporosis research in men, the genetics of 
sex determination, heart disease in women, 
stem cell research, animal research, nutrige-
nomics and degendering knee implants. The 
article concludes with a short review of policy 
at the Canadian, US, and European institutes 
of health, medical curricula, and policies for 
peer-reviewed journals in relation to reporting 
sex/gender analysis in research.
Keywords 
Gendered Innovations, sex and gender analy-
sis, biomedicine, health research
1 Introduction
Since 1993, the U.S. National Institutes of Health (NIH) has required that women and 
minorities be included in phase III clinical trials. Interestingly, this policy was legislated 
in the U.S. Congress through a political process rather than emerging from notions of 
excellent science. Congress required that NIH grantees include women and minority 
groups in human subjects research to “ensure that the [clinical] trial is designed and 
carried out in a manner suffi cient to provide for a valid analysis of whether the variables 
being studied in the trial affect women or members of minority groups, as the case may 
be, differently than other subjects in the trial” (National Institutes of Health 1993: c). 
Cost was not allowed as an acceptable reason for exclusion. This requirement applied 
only to phase III trials, meaning that sex was not considered in preclinical research. 
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In many instances, females were not tested until late in the process. The result is that 
researchers did not see anything unique to females in the discovery phase; they also did 
not see important sex differences that might infl uence outcomes.
One measure of the failure of these policies is failed drugs. Between 1997 and 
2000, for example, ten drugs were withdrawn from the US market because of life-
threatening health effects. Eight of these posed “greater health risks for women than for 
men”  (United States General Accounting Offi ce 2001: 1). Not only does developing a 
drug in the current market cost billions, but when drugs failed they caused human suf-
fering and death. Currently, only about fi ve per cent of drug candidates come to market 
 (Arrowsmith 2011; Herper 2013). 
In 2010, all 13 institutes of which the Canadian Institutes of Health Research (CIHR) 
is composed required applicants to consider sex and gender in their research. The CIHR 
states that “the purpose of this tool is to give health researchers a framework for thinking 
through how gender and/or sex might be integrated into their research designs” (Cana-
dian Institutes of Health Research 2012: para. 2). In December 2013, to better meet its 
grand societal challenges, the European Commission implemented policies to integrate 
sex and/or gender analysis in research and innovation (R&I). In the proposal template, 
under “concept and approach”, applicants are asked “[w]here relevant, describe how sex 
and/or gender analysis is taken into account in the project’s content” (European Com-
mission 2011: 19; 2013: 2; 2014: 7). And since 2014 the NIH has implemented policies 
that “require applicants to report their plans for the balance of male and female cells 
and animals in preclinical studies unless sex-specifi c inclusion is unwarranted, based on 
rigorously defi ned exceptions” (Clayton/Collins 2014: 283).
Now researchers need to be trained to do sex and gender research in basic and 
applied sciences. Interestingly, the European Commission has been the global leader in 
policy related to sex and gender in research. In 2001, the Commission already sought 
to integrate “the gender dimension” into research by requiring that researchers question 
“systematically whether, and in what sense, sex and gender are relevant in the objectives 
and in the methodology of projects” (European Commission 2003: 8). This policy was 
not overtly successful, and reasons put forward in “Stocktaking 10 years of ʻWomen 
in Science’ policy by the European Commission 1999–2009”, among other arguments, 
pointed to confusion about the meaning of “the gender dimension” and a need for more 
guidance for researchers (European Commission 2010: 218ff.). Few institutions of high-
er education have integrated sex and gender analysis into science, health and med icine, 
and engineering curricula. The Erasmus project European Gender in Medicine (EUGiM) 
brought together seven European universities to develop a fl exible Master programme 
ready to be incorporated into local curricula,1  and the Charité – Universitätsmedizin 
Berlin has mainstreamed gender medicine across its core curriculum  (Ludwig et al., 
forthcoming).
Few researchers, then, are prepared to carry out sophisticated sex and gender anal-
ysis. This is the problem Gendered Innovations set out to solve. Gendered Innovations 
began at Stanford University in 2005 with a major conference (Schiebinger 2008). The 
European Commission supported the project in January 2011 and the U.S. National Sci-
ence Foundation joined in January 2012. The project has consisted of an international, 
1 See http://gender.charite.de/en/education/eugim/.
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interdisciplinary collaboration of over 60 experts from across Europe, the United States, 
and Canada. The Republic of Korea has recently joined the effort. 
This project: 1) develops state-of-the-art methods of sex and gender analysis for 
scientists (including health and biomedical researchers) and engineers; and 2) provides 
case studies to illustrate concretely how sex and gender analysis leads to innovation.
What is important in this project is understanding how sex and gender should be 
considered in each step of the research process, from strategic considerations for estab-
lishing priorities and theory to more routine tasks of formulating questions, designing 
methodologies, and interpreting data. Each of the seven methods listed in Figure 1 helps 
researchers pose questions, for example when setting research priorities or developing 
basic conceptual frameworks for a project, in order to integrate sex or gender consid-
erations into that step of the research process. 
Sex and gender analysis is not just 
one thing researchers do – it is not one 
question. Sex and gender analysis in-
forms each step within the research proc-
ess. State-of-the-art methods of sex and 
gender analysis work alongside other 
methodologies in a particular fi eld to pro-
vide yet further “controls” (or fi lters for 
bias), enhancing excellence in science, 
medicine, and engineering research, poli-
cy, and practice. The methods of sex and 
gender analysis are one set of methods 
among many that researchers will bring 
to a project. As with any set of methods, 
new ones will be fashioned and others 
discarded as circumstances change. The 
value of their implementation depends on 
the creativity of the research team. Some 
of these methods plus their practical application in case studies are summarized below.
Gender researchers from the humanities and social sciences will recognize that our 
methods are based on 40 years of gender studies of science, medicine, and technology. 
Gender theory has done much to transform the humanities and social sciences, yet it has 
had little success in the natural sciences and engineering. Health and medical sciences 
represent a middle ground between the two. Humanistic gender theory has been deeply 
infl uenced by feminist biologists and medical research, especially in formulating new 
understandings of sex.  Anne Fausto-Sterling’s work on sex and race in osteoporosis, 
for example, drove home the point that sex (the very bones that support the human 
frame) are formed by cultural norms related to exercise, diet, customs, and modes of 
life  (Fausto-Sterling 2005 and 2008). Suzanne Kessler’s work on intersex further drove 
home the point that even “sex” is not a given, but varies with medical, psychological, 
and parenting practices (Kessler 1998). Further, the complications of (trans)gender have 
led to further scrutiny of efforts to analytically distinguish sex/gender (Rippon et al. 
2014).
Figure 1:  Methods of sex and gender 
analysis
1. Rethinking research priorities and outcomes
2. Rethinking concepts and theories
3. Formulating research questions
4. Analyzing sex
5. Analyzing gender
6. Analyzing how sex and gender interact
7. Analyzing factors intersecting with sex and 
gender
Source: authors’ fi gure.
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2 Methods and case studies
Evidence shows that integrating sex and gender analysis into basic and applied research 
enhances excellence in science, health and medicine, and engineering research, policy, 
and practice (Klinge 2008; Wajcman 2007; Schraudner 2010). Historically, feminists 
have critiqued science and technology after the fact. A rich and important literature 
has critiqued science and technology from multiple gender points of view (reviewed in 
Schiebinger 2014a). Gender experts are now turning critique toward a positive research 
program that – from the beginning – integrates gender analysis into basic and applied 
research. This is the goal of the Gendered Innovations projects. Again, the novelty of 
our approach is showing how sex and/or gender can be integrated as one aspect into 
each step of the research process (see Figure 2). The proximate goal is to avoid gender-
blind research, gender critique, and retrofi tting research to include sex or gender. The 
ultimate goal is to harness the creative power of sex and gender analysis to make new 
discoveries. The owl of sex and gender analysis must fl y at dawn.
Figure 2: Phases of sex and gender analysis
 
Source: authors’ fi gure.
Method 1: Rethinking research priorities and outcomes
Case study: Osteoporosis research in men 
Gendered Innovations has developed 25 case studies through a series of collaborative 
international workshops. In what follows here, we present seven of our twelve methods 
and the associated practical application (or case studies) related to health and biomedi-
Sex and Gender Analysis
Enhances all phases of research
  Setting Research Priorities
  Making Funding Decisions
  Establishing Project Objectives
  Developing Methodologies
  Gathering & Analyzing Data
  Evaluating Results
  Developing Patents
  Transferring Ideas to Markets
  Drafting Policies
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cal research. (Case studies related to technology, basic science, and environment can 
be found on our website.) These materials are drawn from the Gendered Innovations 
website, where readers can fi nd the full methods and case study plus all references to 
original research and a list of contributors who assisted in developing these materials 
(Schiebinger et al. 2011–2015). Each short example here highlights a problem, a method 
of sex or gender analysis, and solutions or Gendered Innovations. 
The fi rst method (rethinking research priorities and outcomes) poses questions to re-
searchers to assist them in considering sex or gender when setting research priorities 
and outcomes.  Governments, industries, funding agencies, and scientists themselves 
set priorities for future research. Research priorities respond to numerous social imper-
atives and background assumptions, such as intended markets, funding levels, lobbies, 
and notions about gender. Questions related to gender include: How do gender norms, 
behaviours, and attitudes infl uence research priorities? Do established practices and 
priorities of funding agencies enforce gender bias or encourage gender equality and 
innovation?
Every research project begins by setting priorities, i.e. choosing how to invest limit-
ed social and intellectual resources, and what questions to pursue. Discussing research 
priorities and outcomes is complex; here space allows for one example from osteopo-
rosis research. 
A number of our case studies examine problems that arise when the male is taken 
as the norm (see, for example, the “genetics of sex determination” and “heart disease 
in women” case studies below). “Osteoporosis research in men”, by contrast, reveals 
how assuming a female default can be detrimental to men. One gendered innovation is 
setting men as a priority in osteoporosis research. 
Osteoporosis has long been defi ned as a disease primarily of post-menopausal 
wom en, an assumption that has shaped its screening, diagnosis, and treatment. Why is 
this a problem? It is true that women suffer more from osteoporosis than men and at an 
earlier age. Men over the age of 75, however, account for a third of hip fractures, and 
when men break their hips, they die more often than women (Burge et al. 2007). Men, 
too, need to be factored into osteoporosis research.
Despite the relatively high numbers of men who suffer from osteoporosis, the basic 
diagnostics for the disease were developed using young, white women (aged 20–29 
years; Centre for Disease Control and Prevention 2002). A key gendered innovation in 
this particular case study came in 1997 when a reference population of young men was 
established to diagnose osteoporosis in men. Although reference populations for men 
have been developed, in men the disease is still identifi ed using the female diagnostic 
cut-off. More research is needed to determine whether or not this cut-off applies to men 
(Szulc et al. 2012). 
Research projects typically employ a number of methods of sex and gender re-
search. In this case, the discerning reader will have zeroed in on the fact that reference 
populations discussed above are white. Method 7 (analyzing factors intersecting with 
sex and gender) pushes researchers to go beyond looking only at sex and gender to con-
sider differences among men with different lifestyles. Bones respond to biological pre-
conditions as well as to lifestyle (diet, smoking, exercise; Fausto-Sterling 2005, 2008). 
Lifestyles can differ dramatically across cultures, ethnicities, and socio-economic class. 
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Current studies are analyzing cohorts of men from China and Sweden, for example, to 
understand these types of differences. The goal is to maintain healthy bones in diverse 
populations. 
Method 2: Rethinking concepts and theories
Case study: Genetics of sex determination
Our second method (rethinking concepts and theories) is applied in the case study on 
the genetics of sex determination. Theories provide frameworks for explaining and pre-
dicting phenomena; concepts relate to how data are described and interpreted, including 
how particular phenomena are categorized. Theories and concepts frame how research 
is conducted within a particular fi eld or topic area, infl uencing: what constitutes an 
interesting research topic; what requires explanation; what counts as evidence; how 
evidence is interpreted; and what methods are considered appropriate. The case study 
on the genetics of sex determination provides an example of how questioning a basic 
concept from a gender perspective (in this case the notion of the female developmental 
pathway as a “default”) opened new areas to research.
Until about 2010, research on sex determination (the differentiation of the embry-
onic bipotential gonad into a testis or an ovary) focused primarily on testis develop-
ment (Uhlenhaut et al. 2009; Richardson 2013). Andrew Sinclair’s 1990 Nature paper 
famously identifi ed a Y-chromosome gene as the Sex-Determining Region Y (SRY; 
 Sinclair et al. 1990). SRY and its downstream targets, such as SOX9, became the focus 
of research. Female sexual development, by contrast, was thought to proceed by “de-
fault” in the absence of SRY. 
“Default” means “failure to act; neglect” or “a preselected option adopted […] 
when no alternative is specifi ed”. In the case of sex determination, “default” became the 
prevailing concept framing research into female pathways, i.e. it was assumed that an 
ovary results in the absence of other action. In the case of the genetics of sex determina-
tion, biologists failed to question the “default” model for ovarian development inherited 
from the 1950s and 1960s. The notion of a “passive” female fi ts with current scientifi c 
theories and gender assumptions in broader society. The active processes controlling 
ovarian development remained unexplored.
Rethinking foundational concepts, questioning the notion of “default”, led to new 
ques tions about ovarian development and the discovery of a cohort of genes required 
for ovarian function (see Figure 3). Gender analysis led to three innovations in this fi eld:
1.  The recognition of ovarian determination as an active process (Veitia 2010). These 
investigations have also enhanced knowledge about testis development, and how 
the ovarian and testicular pathways interact.
2.  The discovery of ongoing ovarian and testis maintenance. Research into the ovarian 
pathway revealed that the transcriptional regulator FOXL2 must be expressed in 
adult ovarian follicles to prevent “transdifferentiation of an adult ovary to a testis” 
(Uhlenhaut et al. 2009). Subsequently, researchers found that the transcription fac-
tor DMRT1 is needed to prevent the reprogramming of testicular Sertoli cells into 
granulosa cells (Matson et al. 2011). 
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3.  New language to describe gonadal differentiation. Researchers have dismissed the 
concept of “default” and emphasize that, while female and male developmental 
path ways are divergent, the construction of an ovary (like the construction of a testis 
or any other organ) is an active process. Each pathway requires complex cascades 
of gene products in proper dosages and at precise times. 
Figure 3: Sex determination
Source: Adapted with permission from Sekido & Lovell-Badge (2009). 
Molecular and Genetic Events in Mammalian Sex Determinaltion
Genes in the female pathway repress Sox9; genes in the male patheway express it.
“The bipotential genital ridge is established by genes including Wt1 and SF1, the early expression of which might 
also initiate that of Sox9 in both sexes. ß-catenin can begin to accumulate as a response to Rspo1-Wrt4 signaling at 
this stage. In XX supporting cell precursors, ß-catenin levels could accumulate suffi ciently to repress SOX9 activity, 
either through direct protein interactions leading to mutual destruction, as seen during cartilage development, or 
by a direct effect on Sox9 transcription. However, in XY supporting cell precursors, increasing levels of SF1 activate 
Sry expression and then SRY, together with SF1, boosts Sox9 expression. Once SOX9 levels reach a critical threshold, 
several positive regulatory loops are initiated, including autoregulation of its own expression and formation of 
feed-forward loops via FGF9 or PGD2 signaling. If SRY activity is weak, low or late, it fails to boost Sox9 expression 
before ß-catenin levels accumulate suffi cientlty to shut it down. At later stages, FOXL2 increases, which might help, 
perhaps in concert with ERs, to maintain granulose (follicle) cell differentiation by repressing Sox9 expression. In the 
testis, SOX9 promotes the testis pathway, including Amh activation, and it also probably represses ovarian genes, 
including Wnt4 and Foxl2. However, any mechanism that increases Sox9 expression suffi ciently will trigger Sertoli cell 
development, even in the absence of SRY“ (Sekido et al., 2009).
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Method 3: Formulating research questions
Case study: Heart disease in women
Our third method (formulating research questions) is applied in our case study on 
heart disease in women. Research questions typically fl ow from priorities and from 
the theories and concepts that frame research (see above). Research priorities (along 
with concepts and theories) function to: 1) delimit questions asked (and, by implication, 
ques tions not asked), and 2) frame research design and choice of methods. The choice 
of questions asked is often underpinned by assumptions – both implicit and explicit – 
about sex and gender. Formulating new research questions constitutes Method 3. 
Heart disease research in women offers one of the most developed examples of 
gendered innovations. Although heart disease is a major killer of women in developed 
countries, it has been defi ned primarily as a male disease, and “evidence-based” clinical 
standards have been created based on male pathophysiology and outcomes. As a result, 
women are often mis- and under-diagnosed (Oertelt-Prigione et al. 2012).
Improving women’s healthcare has required new social, medical, and political judg-
ments about women’s social worth, and a new willingness to support women’s health 
and well-being. Analyzing sex and gender in heart disease has also required formulat-
ing new research questions about disease defi nitions, symptoms, diagnosis, prevention 
strategies, and treatments. Once sex and gender were factored into the equation, knowl-
edge about heart disease increased dramatically. As is often the case, including women 
subjects – of diverse social and ethnic backgrounds – in research has led to a better 
understanding of disease.
To take just one example, consider how underlying pathophysiology may differ 
between women and men (Bairey Merz et al. 2010). Coronary angiography, the “gold 
standard” for diagnosing patients with chest pain, typically results in a diagnosis of ob-
structive coronary artery disease (CAD) in men (see Figure 4, right) but frequently fails 
to identify the cause in a large proportion of women (Bugiardini/Bairey Merz 2005). As 
a result, many women with chest pain but “normal” angiograms (see Figure 4, left) may 
be told that they have no signifi cant disease and sent home. 
Figure 4: Coronary angiograms for patients with ischemic heart disease (IHD)
 Source: Adapted with permission from Gould (1999). 
Pressure Pressure
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New studies show, however, that the prognosis for these women is not benign: Women 
with a primary diagnosis of “non-specifi c chest pain” may suffer heart attack or stroke 
shortly after being discharged from hospital (Robinson et al. 2008). This may also be 
true for some men. Large-scale randomized trials are needed to better understand the 
pathophysiology and optimal therapies for women and men with angina and “normal” 
angiograms. 
After 20 years of research, sex and gender analysis has prompted policy changes, 
increased the representation of women subjects in heart disease research, and enhanced 
knowledge about diagnosis and treatment in women and men alike. In addition, robust 
prevention campaigns have utilized understandings of gender to promote heart-healthy 
behaviours, such as exercise and tobacco and smoking cessation.
Method 4: Analyzing sex
Case study: Stem cells
Our fourth method (analyzing sex) is applied in our case study on stem cells. Sex (re-
ferring to biological qualities, as discussed above) is an important variable to consider 
when setting research priorities, developing hypotheses, and formulating study designs. 
In biomedical research, sex may need to be analyzed in humans, animals, organs,  tissues, 
cells, and their components (Institute of Medicine 2012; Wizemann/Pardue 2001). In 
engineering, sex may need to be analyzed at the levels of user physiology and biome-
chanics in both product and systems design. 
Analyzing sex involves at least fi ve steps: 1) reporting the sex of research subjects 
or users; 2) recognizing differences that exist between but also within groups of females 
and males, and identifying potential overlap between groups (see Figure 5); 3) collect-
ing and reporting data on factors intersecting with sex in study subjects or users/con-
sumers, such as age, socio-economic status, and ethnicity; 4) analyzing and reporting 
results by sex; and 5) reporting null fi ndings. This fi nal step is important: Researchers 
should report when sex differences (main or interaction effects) are not detected in their 
analyses to reduce publication bias and improve meta-analyses. 
Method 4 (analyzing sex) is basic and commonly used in Gendered Innovations 
case stud ies, including animal research, environmental chemicals, nutrigenomics, 
and pregnant crash test dummies. Here we take an example from stem cell research. 
Stem cell therapies hold great promise for treatments for debilitating diseases, such as 
Parkinson’s disease and muscular dystrophy, although few are currently in use. 
Oddly enough, most research today is still done in males (Beery/Zucker 2011). A 
2011 Mayo Clinic study showed that for the most part the sex of the cell is not reported 
(Taylor et al. 2011; see Figure 6). This is money wasted, research that is lost to future 
meta-analysis.
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Figure 5: Within-group variation and between-group overlap
Adults ages 18–86 in 2007. Source: U.S. Centers for Disease Control (CDC) (2007). 
Figure 6: Percentage of articles reporting the sex of cells
Source: Taylor et al. (2011).
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Not taking the sex of the cell into account can lead to life-threatening consequences and 
leave researchers with unsolved puzzles. For example, an international collaboration 
between labs in Norway and Australia encountered problems working with bone mar-
row stem cells in mice. Researchers in the labs appropriately used both male and female 
mice (excellent research design), but they used all female stem cells without considering 
why. This was an unconscious decision that does not refl ect best scientifi c practice. The 
result was that their male mice died – and they did not understand why.  
Taking sex into account will be important when it comes to advancing basic knowl-
edge. Research has documented potential sex differences in the therapeutic capacity of 
stem cells. Muscle-derived stem cells, for example, show variability in proliferation and 
differentiation. Researchers found that XX cells showed a higher regenerative capacity 
than XY cells. This may constitute an important clinical fi nding, but requires further 
investigation. Researchers should consider all combinations of donor/recipient sex in-
teraction before ruling out sex as a variable. This type of donor/recipient analysis has 
also been important in human organ transplant (Kaczmarek et al. 2013). 
The effects of sex, however, may also vary by type of stem cell used, type of dis-
ease treated, and hormonal and environmental factors, plus their intersections. It is 
complicat ed, but research that takes these factors into account leads to better outcomes.
 
Method 5: Analyzing gender
Case study: Animal research
Our fi fth method (analyzing gender) is applied in our case study on animal research. 
While many Gendered Innovations methods integrate gender in various phases of the 
research process, this method provides the techniques for analyzing gender, a major tool 
for identifying unconscious bias. Gender is a primary linguistic, cognitive, and analyt-
ical category in science, health and medicine, and engineering. Yet gender assump tions 
often go unquestioned and hence remain invisible to scientifi c communities. These 
background assumptions unconsciously infl uence scientifi c priorities, research ques-
tions, and choices of methods, as we have seen. Gender comes into play when cultural 
attitudes shape and are shaped by: 1) researchers’ gender assumptions and behaviours 
as these relate to the proposed research, 2) research subjects’ and users’ gender needs, 
assumptions, and behav iours as these relate to the proposed research, 3) the interaction 
between numbers 1 and 2.
The case study on animal research investigates how gender, by which we mean key 
“socio-cultural” (environmental) factors, infl uence biomedical experiments with ani-
mals. Understanding how to take into account “gender-based” confounders and how 
to study the infl uence of “gender” on biology may increase the translational value of 
research in animals to humans.
What is gender, and can we discuss it in relation to animals? Defi nitions of gender 
abound. Here we highlight three approaches:
• Gender norms refer to researchers’ differing attitudes toward male or female ani-
mals. Researchers may act on gender stereotypes concerning expected behaviours 
of male and of female animals. 
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• Gender relations refer to social interactions between female and male animals, on 
the one hand, and between animals (of differing sex) and men and women research-
ers (with potential differing gender expectations), on the other.
• Gender identities refer to how individuals perceive and present themselves, and 
how they are perceived by others. There is no evidence that rodents develop con-
scious gender identities. 
Figure 7: Animal research includes analyzing sex and gender
As a fi rst example of “gender” in relation to animals, we will look at caging practices. 
Male rodents are often caged in small groups or alone (because they fi ght). Rodents 
housed alone “expend more energy maintaining body temperature, which can cause 
differences in parameters such as caloric intake, muscle activity, metabolic rate, fat dis-
tribution, or body size, with a plethora of potential downstream effects on bodily and 
cellular activity” (Ritz et al. 2014: 8). In other words, animals caged individually use 
more energy to maintain body temperature. This can impact basic metabolism. Animals 
housed together tend to sleep clustered together and, as a result, expend less energy to 
keep warm. Importantly, differences in caging practices between male and female ani-
mals should not be mistaken for biological sex differences.
Animal research includes analyzing sex (biological characteristics, such as genes, hormones, age, repro-
ductive phase, strain etc.) and gender (socio-cultural or environmental process, such as caging practices, 
attitudes and behaviours of researchers, room temperature, diet etc.). The double-ended arrows represent 
interactions between sex and gender.  Source: authors’ fi gure.
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The solution may not be as simple as housing females and males in the same con-
ditions. The same sized group may create different stressors for females and males, 
and being caged alone may itself cause stress (Ritz et al. 2014). It is crucial that all 
researchers describe housing conditions, specifying the number of animals per cage 
(Prendergast et al. 2014).
A second example of where gender matters in animal research has to do with gender 
relations, i.e. the dynamic between the sex of the research staff and the animal’s reaction. 
Interestingly, experimenter sex may be a confounding variable in rodent research where 
stress is a signifi cant factor. Sorge et al. (2014) found that rats and mice demonstrated 
a reduced pain response in the presence of a male experimenter, as compared with an 
 empty room, whereas the presence of a female experimenter produced no difference. Both 
male and female rodents showed this response, but females had a greater effect. T-shirts 
worn by men for a night and bedding from other male mammals, including predator and 
nonpredator species, produced the same analgesic effect. The researchers identifi ed this 
“‘male observer’ effect” (Sorge et al. 2014) as a stress response to androstenone and an-
drostadienone, axillary secretions found in higher concentrations in males than in females. 
In this example, the sex of the experimenter matters. Standard laboratory practice 
will need to account for experimenter sex when this is shown to have an effect. All too 
often “sex differences” in research animals are reported where more complex interac-
tions that involve gender or, in this case, lab conditions may be at work.
Method 6: Analyzing how sex and gender interact
Case study: Nutrigenomics 
Our sixth method (analyzing how sex and gender interact) is applied in our case study 
on nutrigenomics. “Sex” and “gender” are distinguished for analytical purposes. In real-
ity, sex and gender interact (i.e. mutually shape one another) to form individual bodies, 
cognitive abilities, and disease patterns, for example. And, as we shall see in Method 7 
(analyzing factors intersecting with sex and gender), sex and gender intersect in impor-
tant ways with a variety of other social factors, including age, educational background, 
socio-economic status, ethnicity, geographical location, etc. 
The image from Vera Regitz-Zagrosek below (Figure 8) suggests how sex and gen-
der interact to create individual behaviours, health outcomes, and attitudes etc. across 
the life span. Although women and men are fundamentally alike, sex and gender can 
work together to produce different outcomes.
How sex and gender interact can be illustrated in the case study on nutrigenomics. It 
examines the epidemic of non-communicable diseases (e.g. heart disease, diabetes, and 
cancers) that are on the rise across Europe and North America.
Figure 9 shows the hypothetical relative infl uences of sex- and gender-related fac-
tors determining a person’s disease risk over her or his lifetime. Importantly, gender-
related social factors (such as obesity, lack of exercise etc.) interact with sex-related 
biological factors (such as genetic predispositions and hormones) to determine how a 
person ages. For instance, to understand differences in women’s and men’s obesity rates, 
we need to analyze gender differences in lifestyle. Perhaps gender norms in society lead 
men to exercise more than women; this can lead to greater disease among women. Or 
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perhaps gender norms in society lead men to eat less healthy food than women. This 
gendered behaviour can lead to greater disease among men.
Figure 8: Complex interdependency of sex and gender throughout the human life cycle
Source: Regitz-Zagrosek (2012).
Figure 9: Cumulative life risk factors for non-communicable diseases
Source: Adapted from Darnton-Hill/Nishida/James (2004).
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In Figure 10 we see how gender-related food intake can be translated into sex-specifi c 
basic metabolism and gene expression, and, fi nally, into sex-specifi c responses to die-
tary interventions. Nutritionists have used sex analysis to explore – at the functional, 
mechanistic level – how nutrients affect gene expression and cell function in women and 
men. In one study, they examined vitamin E/gene interactions affecting the incidence of 
respiratory tract infections in the elderly. The main fi nding suggested that the effect of 
vitamin E differed by sex: only in women (with a certain genotype) did vitamin E reduce 
respiratory tract infections.
Figure 10: Gendered model for analyzing mechanisms involved in food intake and 
processing
Source: authors’ fi gure (by courtesy of Bart Penders).
Method 7: Analyzing factors intersecting with sex and gender
Case study: Degendering the knee
Our seventh method (analyzing factors intersecting with sex and gender) is applied in 
our case study on degendering the knee. This method applies to nearly every research 
project – and it is often a game changer. Intersecting factors, such as ethnicity or socio-
economic background, may reveal sub-group differences among women and among 
men that are obscured when analyzing only gender or only sex. Researchers can investi-
gate how sex and/or gender intersect with other signifi cant factors by: 1) identifying all 
relevant factors, 2) defi ning those factors, and 3) identifying intersections between those 
variables. These factors can be biological, socio-cultural, or psychological, and may 
include genetics, age, sex hormones, reproductive status, body composition, comorbidi-
The diagram above illustrates how researches might analyze a three-way interaction between gender-related factors, 
sex-specifi c biology, and various biological mechanisms involved in human food intake and processing. Gender-
related food intake is translated into different sex-specifi c base metabolism, gene expressions, and dietary responses, 
thereby making nutrigenomics a pervasive Gendered Innovation.
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ties, body size, disabilities, ethnicity, nationality, geographical location, socio-economic 
status, educational background, sexual orientation, religion, lifestyle, language, family 
confi guration, environment etc.
The case study on degendering the knee provides a cautionary tale. As we have 
seen, it is crucial to test for sex and gender differences before ruling them out. However, 
sex differences should not be overemphasized or studied to the exclusion of other in-
tersecting factors. Researchers often overemphasize differences and neglect the overlap 
or sameness between the sexes (for a discussion of this applied to gender, see Hyde 
2014). Overemphasizing sex differences can lead to three types of errors : First, sex dif-
ferences may be asserted without suffi cient evidence or documentation. As noted above, 
the bias against reporting negative or null results means that fi ndings of sex differences 
are reported more often than fi ndings of no sex difference (Institute of Medicine 2012). 
Second, differences between men and women may be improperly attributed to sex 
(a biological quality) when in fact cultural factors, such as socio-economic factors, come 
into play. Third, sex may be emphasized to the exclusion of other important variables, as 
illustrated in the case study on degendering the knee. 
This case study treats knee replacements, i.e. the prostheses that are implanted to 
replace worn-out knees. In 2007, an estimated 500,000 total knee arthroplasty (TKA) 
procedures were performed worldwide, about two thirds in women. In the 1990s, with 
increased attention to women’s health research, manufacturers, such as Zimmer Inc., 
began producing “gender-specifi c” knees and marketing them directly to women. Did 
this lead to better healthcare quality?
Sex may appear to be the most important variable in choosing a knee implant until 
height is considered. Specifi cally, research shows that two anatomical sex differences 
(greater Q-angle and lesser anterior condylar height in women) disappear when correct-
ed for standing height. This suggests that height may be more important than sex in 
determining the knee implant a patient should receive.
It is important to analyze sex differences before ruling them out. Many additional 
factors, however, infl uence outcomes in TKA, including age, body composition, comor-
bidities, preoperative knee mobility, ethnicity, and surgeon or hospital volume.
This case study demonstrates the importance of reporting null results. Finding no 
sex effect is as important as fi nding a sex effect. To reduce publication bias, researchers 
should report when sex differences (main or interaction effects) are not detected or when 
data regarding sex differences are statistically inconclusive (Wizemann, 2012). Publish-
ers often do not report negative fi ndings. Publishing only positive sex differences, how-
ever, runs the risk of overemphasizing sex difference and underplaying sameness. With 
respect to sex, reporting negative results is crucial for meta-analysis.
3 Conclusions and policy recommendations 
Gendered Innovations has moved gender studies beyond identifying gender bias to 
 prioritizing sex and gender analysis as a resource to create new knowledge and tech-
nology. The key step is – from the beginning – to incorporate sex and gender analysis 
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into each step of the research process. This move from being reactive to being proactive 
means that researchers have a better chance of getting it right the fi rst time. Discoveries, 
pharmaceuticals, technologies, and the like will no longer need to be retrofi t to the ne-
glected sex. Incorporating sex and gender as robust variables into research (as described 
in the seven methods discussed here) can fuel life-saving research and protect public 
resources. 
Such research thrives on interdisciplinary work. Interdisciplinarity requires shared 
conceptual frameworks and vocabularies. It also thrives on a willingness to meet part-
ners half way. The Gendered Innovations project has hopefully developed methods that 
are beginning to facilitate this type of interdisciplinary, global research. 
We close with a few policy recommendations. Policy is one driver of research and 
discovery and it can encourage scientists to integrate sex and gender analysis into their 
research. Interlocking policies need to address gate keepers, i.e. granting agencies, hir-
ing committees, editors of peer-reviewed journals, industry leaders, and educators. 
3.1  Granting agencies
As discussed above, granting agencies implemented policies in the 1990s to support 
women’s health research and in the 2010s to support sex and gender analysis in re-
search. A new study has evaluated the overall return on public funding to society of one 
study, the U.S. National Institutes of Health Women’s Health Initiative oestrogen plus 
progestin clinical trial. This large, government-funded trial was done in the 1990s and 
cost $260 million. The study found that the return for every $1 spent was $140. Overall, 
the net economic return of the research returned $37.1 billion. 
More than money, the study also saved lives in the form of 76,000 fewer cases 
of cardiovascular disease, 126,000 fewer breast cancers, and 145,000 more quality-ad-
justed life years. While most of the results were positive, the analysis did fi nd 263,000 
more osteoporotic fractures (Roth et al. 2014). While we know that research done wrong 
can cost money and lives, this evaluation shows that research done right can save money 
and lives.
Another study evaluated the impact of the CIHR policy implemented in 2010 that 
required applicants to indicate whether their research designs accounted for sex or gen-
der. The study showed that the mandatory questions led to an overall increase in the 
proportion of funded research that incorporated sex and gender in their research de-
signs. Results varied by discipline, with biomedical researchers being least likely to 
account for sex and gender, clinical researchers being most likely to account for sex, 
and population health researchers being most likely to account for gender. Interestingly, 
women principal investigators were more likely to incorporate sex and gender than their 
male counterparts. A qualitative portion of the study found that research requires more 
guidance on how to do this research. Many, for example, confl ated sex and gender; 
a number assumed that studying women was equivalent to studying sex and gender 
 (Johnson et al. 2014).
More granting agencies are requiring sex and gender analysis in order to fund re-
search. We expect the European Research Council and the U.S. National Science Foun-
dation to implement such requirements for the life sciences and engineering, or any 
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fi eld with human endpoints. The Korean National Research Foundation is considering 
similar measures. 
3.2 Editorial boards of peer-reviewed journals 
Editorial policies of peer-reviewed journals can contribute to regulating excellence in 
research by requiring sophisticated sex- or gender-based analysis when selecting papers 
for publication. A number of journals have implemented this policy. Clinical Orthopae-
dic and Related Research has recommended that studies be suffi ciently powered to ana-
lyze sex (Leopold et al. 2014). In 2012, each of the American Physiological Society’s 14 
journals required that authors report and analyze sex (Miller 2010). Science and Nature 
are considering such policies.
 
3.3 Universities 
Universities have two important jobs that urgently need to be undertaken: 1) Large 
“methods and techniques” workshops need to be implemented so that researchers can 
exchange strategies for effi ciently and effectively integrating sex and gender into re-
search. Norway’s University of Tromsø has developed an excellent model of hosting 
such a workshop plus offering funding supplements to researchers for incorporating sex 
or gender. The idea was to ready their researchers to apply for Horizon 2020 monies. 
Stanford’s Gendered Innovations along with Stanford’s Women and Sex Differences in 
Medicine Center have hosted such workshops. The NIH’s Offi ce of Women’s Health 
and Research also hosted a national a workshop on methods in biomedical science in 
October 2014. It is crucial that universities and national organizations take the lead 
when it comes to training the current generation of researchers in sex and gender anal-
ysis. 2) Universities must immediately integrate the results of Gendered Innovations 
into their curricula. In medicine and public health in particular teaching new materials 
that incorporate sex and gender can be a matter of life or death. Sweden’s Karolinska 
Institute and Germany’s Charité – Universitätsmedizin Berlin have both created centres 
for gender medicine that promote sex and gender analysis in research and medical edu-
cation (Klinge 2008: 10). The next step is to reform the curriculum to incorporate sex 
and gender.
Sex and gender analysis adds value to research by ensuring excellence and quality 
in outcomes and enhancing sustainability. Sex and gender analysis adds value to society 
by making research more responsive to social needs, and it adds value to business by 
developing new ideas, patents, and technology. The goal is to stimulate gender-respon-
sible science and technology, thereby enhancing quality of life for both women and men 
worldwide. Can we afford to ignore such opportunities?
Thanks for support for this work go to the National Science Foundation (Grant No. 
1153160), the European Commission Research & Innovation Science in Society pro-
gramme, and to Stanford University. Conclusions drawn here do not necessarily refl ect 
the views of these institutions. Parts of this article appeared in Schiebinger (2014b).
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